359 related articles for article (PubMed ID: 20212233)
1. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005.
Goldberg MS; Doucette JT; Lim HW; Spencer J; Carucci JA; Rigel DS
J Am Acad Dermatol; 2007 Jul; 57(1):60-6. PubMed ID: 17490783
[TBL] [Abstract][Full Text] [Related]
3. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma and other types of cancer preceding Parkinson disease.
Olsen JH; Friis S; Frederiksen K
Epidemiology; 2006 Sep; 17(5):582-7. PubMed ID: 16837822
[TBL] [Abstract][Full Text] [Related]
5. Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure.
Shore RN; Shore P; Monahan NM; Sundeen J
J Drugs Dermatol; 2011 Mar; 10(3):244-52. PubMed ID: 21369639
[TBL] [Abstract][Full Text] [Related]
6. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
7. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors.
Haenssle HA; Korpas B; Hansen-Hagge C; Buhl T; Kaune KM; Johnsen S; Rosenberger A; Schön MP; Emmert S
Arch Dermatol; 2010 Mar; 146(3):257-64. PubMed ID: 20231495
[TBL] [Abstract][Full Text] [Related]
8. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program.
Geller AC; Sober AJ; Zhang Z; Brooks DR; Miller DR; Halpern A; Gilchrest BA
Cancer; 2002 Oct; 95(7):1554-61. PubMed ID: 12237925
[TBL] [Abstract][Full Text] [Related]
9. Skin cancer and Parkinson's disease.
Ferreira JJ; Neutel D; Mestre T; Coelho M; Rosa MM; Rascol O; Sampaio C
Mov Disord; 2010 Jan; 25(2):139-48. PubMed ID: 20063399
[TBL] [Abstract][Full Text] [Related]
10. Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects.
Carli P; Balzi D; de Giorgi V; Massi D; Palli D; Chiarugi A; Nardini P; Giannotti B
Eur J Dermatol; 2003; 13(5):482-6. PubMed ID: 14693495
[TBL] [Abstract][Full Text] [Related]
11. Routine dermatologist-performed full-body skin examination and early melanoma detection.
Kantor J; Kantor DE
Arch Dermatol; 2009 Aug; 145(8):873-6. PubMed ID: 19687416
[TBL] [Abstract][Full Text] [Related]
12. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.
Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and distribution of melanocytic naevi on the scalp: a prospective study.
De Giorgi V; Sestini S; Grazzini M; Janowska A; Boddi V; Lotti T
Br J Dermatol; 2010 Feb; 162(2):345-9. PubMed ID: 19886886
[TBL] [Abstract][Full Text] [Related]
14. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
[TBL] [Abstract][Full Text] [Related]
15. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
[TBL] [Abstract][Full Text] [Related]
16. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
18. [Melanoma in organ transplant patients].
Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
[TBL] [Abstract][Full Text] [Related]
19. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma.
Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti GL; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Cecchi R; Bottoni U; Bonci A; Scalvenzi M; Giannotti B;
Arch Dermatol; 2003 May; 139(5):607-12. PubMed ID: 12756097
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes from skin screening clinics within a community-based melanoma screening program.
Aitken JF; Janda M; Elwood M; Youl PH; Ring IT; Lowe JB
J Am Acad Dermatol; 2006 Jan; 54(1):105-14. PubMed ID: 16384764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
